|
Volumn 47, Issue 2, 2001, Pages 113-116
|
Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours
a a a a a a a |
Author keywords
5 Fluorouracil; Advanced solid tumours; Levofolinic acid; Mitoxantrone; Raltitrexed
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
FLUOROURACIL;
FOLINIC ACID;
LEVOFOLINIC ACID;
MITOXANTRONE;
RALTITREXED;
UNCLASSIFIED DRUG;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
DOSE RESPONSE;
DRUG TOLERABILITY;
FEMALE;
HEAD AND NECK CANCER;
HUMAN;
MALE;
NAUSEA AND VOMITING;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOLID TUMOR;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
MITOXANTRONE;
NEOPLASMS;
QUINAZOLINES;
THIOPHENES;
|
EID: 0034919480
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800000194 Document Type: Article |
Times cited : (2)
|
References (9)
|